UroGen Pharma Ltd. (URGN)
21.80
-0.56
(-2.50%)
USD |
NASDAQ |
Dec 12, 16:00
21.79
-0.01
(-0.05%)
After-Hours: 20:00
UroGen Pharma EPS Diluted (Quarterly): -0.6939 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 3.171 |
| MeiraGTx Holdings Plc | -0.624 |
| CEL-SCI Corp. | -1.365 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.35M |
| Revenue (Quarterly) | 27.48M |
| Total Expenses (Quarterly) | 60.83M |
| Enterprise Value | 1.022B |
| Gross Profit Margin (Quarterly) | 88.07% |
| Profit Margin (Quarterly) | -121.3% |
| Earnings Yield | -15.88% |
| Normalized Earnings Yield | -15.88 |